Seeing Asteroids in the Dark

A test of the automated navigation system being developed for ESA’s Hera mission. A space-grade camera is imaging a model binary asteroid system in dark conditions representative of deep space illumination. (Credit: GMV)

PARIS (ESA PR) — Hera – named after the Greek goddess of marriage – will be humankind’s first probe to rendezvous with a binary asteroid system, a little understood class making up around 15% of all known asteroids.

NASA will first perform a kinetic impact on the smaller of the two Didymos asteroids, then Hera will follow-up with a detailed post-impact survey will turn this grand-scale experiment into a well-understood and repeatable planetary defence technique. Being able to deflect the orbit of an incoming body in this way could one day help prevent a devastating strike on Earth.

This ‘hardware-in-the-loop’ testing is being performed by GMV in Spain, responsible for developing the Hera mission’s guidance, navigation and control system.

PLD Space Adds GMV as Partner, Receives 6.7 Million Euro Investment

 ARION 1 & 2 technology demonstration. (Credit; PLD Space)
ARION 1 & 2 technology demonstration. (Credit; PLD Space)

ELCHE, Spain, January 9, 2017 (PLD Space PR) — The International Tech Company GMV, with an important presence in the global space sector, has decided to trust in the PLD Space project and will take part in the ownership of the young space company as shareholder. GMV will also develop key technology and will work together with PLD Space in the development of the ARION 1 and ARION 2 launchers, an activity that will enable both companies to grow and position themselves strategically in the small space-launchers market.

The corporative endorsement of GMV enables PLD Space to raise a total investment of 6.7 million euros; between private investment through 2 Spanish investment vehicles and institutional funding coming from the contribution of Spanish government (CDTI and ENISA), public administrations (SUMA Teruel, IVF) and the European Commission (SME Phase1).

(more…)